Ask Spine Surgeons is a weekly series of questions posed to spine surgeons around the country about clinical, business and policy issues affecting spine care. We invite all spine surgeon and specialist responses. Next week's question: What is your number one tip for developing a productive relationship with payors?
Please send responses to Heather Linder at email@example.com by Wednesday, Feb. 20, at 5 p.m. CST.
Vincent Arlet, MD, Orthopedic Spine Surgeon, KneeFootAnkle Center of Kirkland (Wash.): I would like to see more research on junctional syndromes, such as proximal junctional kyphosis and distal junctional kyphosis, after spinal deformity surgery.
Ara Deukmedjian, MD, Neurosurgeon and CEO, Deuk Spine Institute, Melbourne, Fla.: I would like to see research on the joints of the spine. Spinal joints are the cause of back and neck pain over 90 percent of the time and can be effectively treated without surgery in most patients. Your doctor must know which joint is painful in order to perform the correct treatment. Unfortunately, even if the doctor comes up with the correct diagnosis, many are not qualified to perform the treatment correctly. Unless patients are willing to travel, many are destined to live in pain for years.
Jeffrey Goldstein, MD, Director of Spine Service, NYU Langone Medical Center's Hospital for Joint Diseases: The importance of preservation and restoration of sagittal spinal alignment is becoming better recognized and understood. The first step is more studies which continue to evaluate the effect of changes on sagittal alignment and outcomes, adjacent segment degeneration and need for revisions. The second step is to "manage" or "program" sagittal alignment with interbody cages and instrumentation which allow us to enhance lumbar lordosis, for example.
Secondly, with regard to fusion, I would like to see research into surface technology which can enhance interbody fusion. Surface treatments can enhance primary fixation. The next generation of surface structures will allow us to move from a random morphology to a predetermined surface which can direct bony in-growth.
Jeffrey Wang, MD, UCLA Spine Center: I think the future is in the biological realm. Research into the basic mechanisms of the disease processes and developments in biological treatments are the future. In our laboratory, we are working on many novel basic science applications that I would like to see translated into better treatments for our patients. I think we are very close to improving bone healing with faster spinal fusions and with fewer complications. I would like to see biological treatments for disc pathologies come to a realization over the next five years that allow us to have better treatments for our patients and better outcomes. We have a lot of spinal devices and hardware, but in reality, research into the basic mechanisms to understand spinal disease processes will give us a great understanding of our patients' conditions and how to best treat them in the future.
More Articles on Spine:
Shriners Hospital for Children Purchases EOS Imaging System for Spine
Economics, Politics & the Independent Spine Surgeon: Q&A With Dr. Craig Callewart
Can Spine Surgeons Legally Own Interest in ASCs?
Where Should Spine Research Focus? 4 Surgeons Weigh In FeaturedWritten by Heather Linder | Thursday, 14 February 2013 14:15
Four spine surgeons discuss spine-related research.
© Copyright ASC COMMUNICATIONS 2015. Interested in LINKING to or REPRINTING this content? View our policies here.
Most Read - Spine
- Spine surgery in a value-based world: Dr. Jed Vanichkachorn on spine bundled payments
- Hospital employment vs. independent practice: 5 spine surgeons weigh in
- The endless possibilities in spine biologics, artificial disc & outpatient procedures
- 6 surgeons predict what the future may bring for the spine industry
- 5 things to know about Medicare charges for cervical spine surgery
Top 40 Articles from the Past 6 Months
- 12 statistics on neurosurgeon salary in 2015
- North American Spine brings in two new procedures — 5 things to know
- Drs. Larry Lenke, Daniel Riew, Ronald Lehman leaving St. Louis for NYC — 5 things to know
- DePuy Synthes, Stryker, Zimmer, Medtronic lead global orthopedics now — 8 key notes on where they're headed
- Bundled spine surgery for Walmart, Lowe's employees — 6 things to know
- Medtronic is headed for strong 2015 — 8 reasons why
- 5 key trends in 3D printing medical device market
- 25 Spine Device Awards | 2015
- 20 Spine Surgeon Leadership Awards | 2015
- Neurosurgeon named in counterfeit spinal implant lawsuit — 5 things to know
- 10 spine, orthopedic surgeon tech entrepreneurs to know
- A differentiated approach in lateral spine surgery: Oblique lateral interbody fusion (OLIF at L2-L5)
- 15 things to know about Zimmer Biomet
- Top 10 specialties with highest pay — Orthopedists lead the pack
- Dr. Charles Kuntz IV passes away unexpectedly
- Zimmer voluntarily recalls knee device
- Safeguards to Prevent Neurologic Complications after Epidural Steroid Injections: Analysis of Evidence and Lack of Applicability of Controversial Policies
- 6 spine physicians ranked #1 on Google
- Northwestern's Feinberg School of Medicine neurological surgery chief Dr. Andrew Parsa dies
- Are 'macho' orthopedic surgeons a hazard to patients? 5 things to know
- Dr. Aria Sabit pleads guilty to unnecessary spine surgery, faces 11+ years in prison — 5 things to know
- Is the Zimmer-Biomet closed merger finally around the corner? 5 things to know
- Dr. Neal ElAttrache to perform Manny Pacquiao's shoulder surgery: 5 things to know
- Spinal fusion vs. disc replacement: Which costs more? 5 key notes
- Medtronic pays 8 physicians $1M+: 5 key notes
- Building an empire: How Dr. Douglas Won created a physician-led health system
- Another spine surgeon named in "fake implants" lawsuit — This time in Maryland: 5 key notes
- Zimmer Q1 sales drop 2.3%, Biomet merger still not final — 10 things to know
- How The CORE Institute grew 40% last quarter — IT leads the way
- Dr. Sanjay Khurana helps rescue Harrison Ford from crashed air plane
- Is Smith & Nephew's cost-conscious strategy working? 5 key notes
- UPMC's Dr. Tanya Hagen dies at age 45
- Hospitals face 4 lawsuits in connection with unnecessary spine surgeries case — 6 things to know
- How high-energy spine surgeons start their day — 5 things to know
- 55 statistics and issues for neurosurgeons and orthopedic spine surgeons — compensation, global device market and more
- Johnson & Johnson (J&J) sells Cordis line for $1.9B: What it could mean for DePuy Synthes
- Spinal deformity surgery — On the cutting edge with Drs. Isador Lieberman, Suken Shah
- Dr. Ziya Gokaslan to leave Johns Hopkins for Rhode Island Hospital
- Cervical disc replacement Mobi-C vs. spinal fusion: Are there advantages to one? 6 key notes
- Medtronic facing product liability lawsuit over Infuse once more: 9 things to know